Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma
Open Access
- 7 February 2005
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 24 (15) , 2461-2473
- https://doi.org/10.1038/sj.onc.1208447
Abstract
Multiple myeloma (MM) is the most common form of plasma cell dyscrasia, characterized by a marked heterogeneity of genetic lesions and clinical course. It may develop from a premalignant condition (monoclonal gammopathy of undetermined significance, MGUS) or progress from intramedullary to extramedullary forms (plasma cell leukemia, PCL). To provide insights into the molecular characterization of plasma cell dyscrasias and to investigate the contribution of specific genetic lesions to the biological and clinical heterogeneity of MM, we analysed the gene expression profiles of plasma cells isolated from seven MGUS, 39 MM and six PCL patients by means of DNA microarrays. MMs resulted highly heterogeneous at transcriptional level, whereas the differential expression of genes mainly involved in DNA metabolism and proliferation distinguished MGUS from PCLs and the majority of MM cases. The clustering of MM patients was mainly driven by the presence of the most recurrent translocations involving the immunoglobulin heavy-chain locus. Distinct gene expression patterns have been found to be associated with different lesions: the overexpression of CCND2 and genes involved in cell adhesion pathways was observed in cases with deregulated MAF and MAFB, whereas genes upregulated in cases with the t(4;14) showed apoptosis-related functions. The peculiar finding in patients with the t(11;14) was the downregulation of the α-subunit of the IL-6 receptor. In addition, we identified a set of cancer germline antigens specifically expressed in a subgroup of MM patients characterized by an aggressive clinical evolution, a finding that could have implications for patient classification and immunotherapy.Keywords
This publication has 54 references indexed in Scilit:
- Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analysesGenes, Chromosomes and Cancer, 2004
- A Global Expression-based Analysis of the Consequences of the t(4;14) Translocation in MyelomaClinical Cancer Research, 2004
- Advances in biology of multiple myeloma: clinical applicationsBlood, 2004
- Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16·3;q32) in multiple myelomaBritish Journal of Haematology, 2004
- In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expressionBlood, 2003
- GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activityOncogene, 2002
- Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapyBlood, 2002
- THE BIOLOGY AND CYTOGENETICSOF MULTIPLE MYELOMAReviews in Clinical and Experimental Hematology, 2002
- Multiple MyelomaHematology-American Society Hematology Education Program, 2002
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal TranslocationsJapanese Journal of Cancer Research, 2001